Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors.
Jasim SA, Gupta J, Uthirapathy S, R R, Kazmi SW, Rizaev JA, Eldesoqui M, Shallan MA, Mustafa YF, Hosseen B. Jasim SA, et al. Among authors: uthirapathy s. Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 9. doi: 10.1007/s00210-025-04336-z. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40488851 Review.
Anti-metastatic potential of flavonoids for the treatment of cancers: focus on epithelial-mesenchymal transition (EMT) process.
Mohammad SI, Vasudevan A, Nadhim Mohammed S, Uthirapathy S, M M R, Kundlas M, Siva Prasad GV, Kumari M, Mustafa YF, Ali Hussein Z. Mohammad SI, et al. Among authors: uthirapathy s. Naunyn Schmiedebergs Arch Pharmacol. 2025 May 28. doi: 10.1007/s00210-025-04235-3. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40434422 Review.
The SOX gene superfamily in oncogenesis: unraveling links to ncRNAs, key pathways, chemoresistance, and gene editing approaches.
Ahmed AY, Uthirapathy S, Oghenemaro EF, M RM, Kumawat R, Mustafa YF, Kariem M, Kadhim AJ, Sharma S, Kumar MR. Ahmed AY, et al. Among authors: uthirapathy s. Naunyn Schmiedebergs Arch Pharmacol. 2025 May 20. doi: 10.1007/s00210-025-04229-1. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40392306 Review.
circRNA/TLR interaction: key players in immune regulation and autoimmune diseases.
Hsu CY, Bediwi AK, Zwamel AH, Uthirapathy S, Ballal S, Singh A, Sharma GC, Devi A, Almalki SG, Kadhim IM. Hsu CY, et al. Among authors: uthirapathy s. Naunyn Schmiedebergs Arch Pharmacol. 2025 May 6. doi: 10.1007/s00210-025-04221-9. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40328911 Review.
Inflammasomes and autophagy in cancer: unlocking targeted therapies.
Gupta J, Mohammed MH, Alghazali T, Uthirapathy S, R R, Thakur V, Kaur M, Naidu KS, Kubaev A, Al-Mukhtar MM. Gupta J, et al. Among authors: uthirapathy s. Naunyn Schmiedebergs Arch Pharmacol. 2025 May 1. doi: 10.1007/s00210-025-04184-x. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40310530 Review.
45 results